Clinical trial Recruiting at 2 sites Observational Ages 21 and up

Evaluating safety and effectiveness of a procedure for heavily calcified coronary lesions

Official title: ROVUS Asia Registry (Evaluate Safety and Effectiveness of Rotational Atherectomy and Intravascular Ultrasound for Heavily Calcified Coronary Lesion)

Run by National Heart Centre Singapore · NCT04742478 · Data updated 2026-11-12

This study is testing if a special procedure called rotational atherectomy is safe and effective for people with heavily calcified coronary arteries who need a heart procedure.

More Coronary Artery Calcification trials

Quick facts

Study typeObservational
Ages21 Years and up
SexAll
Enrollment1000 (estimated)
SponsorNational Heart Centre Singapore
Academic / other
Locations2 sites (Kitakyushu and 1 other locations)
StatusRecruiting
StartedMarch 10, 2021
Main results expectedFebruary 29, 2024
Study endsDecember 31, 2026
Registry record updatedApril 23, 2021
Trial IDNCT04742478 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with clinically indicated PCI and moderate to severe coronary calcification.

Probably not a fit

Patients who decline to give consent or do not meet the angiographic criteria for calcification will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational multicenter cohort study aims to evaluate the safety and effectiveness of rotational atherectomy in patients with calcified coronary lesions undergoing percutaneous coronary intervention (PCI). Participants will provide informed consent for data collection, which will include demographics, clinical data, and follow-up results. The study will aggregate data from multiple centers across Asia to assess procedural outcomes and complications associated with this treatment approach. The findings will help to understand the representativeness of the data collected and the effectiveness of rotational atherectomy in this patient population.

Why it matters

Potential benefit: If successful, this study could improve treatment outcomes for patients with severe coronary calcification requiring PCI.

How similar studies have gone: Previous studies have shown that rotational atherectomy can be a safe adjunctive procedure for treating heavily calcified lesions, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Able to understand and sign an informed consent form
* Presence of clinical indication for percutaneous coronary intervention (PCI) and/or stent placement
* Subjects willing to comply with all research and follow-up requirements.
* Angiographic criteria (ONE of the following criteria MUST be met)

  1. Target lesions visually have at least moderate calcifications\*
  2. Target lesion balloon dilatation failure
  3. Inability of devices (microcatheters, balloons or stents) to pass through the target lesion.
* Procedural criteria

  1. All patients treated with RA with or without other forms of debulking therapy

     * Moderate calcification is defined as radio-opacities noted only during cardiac cycle prior to contrast injection whereas severe calcification is defined as radio-opacities seen without cardiac motion prior to contrast injection, usually affecting both sides of the arterial lumen.

Exclusion Criteria:

* Decline to give consent

Where it's running

  • Kokura Memorial hospital
    Kitakyushu, Japan
    Recruiting
  • National Heart Centre Singapore
    Singapore, Singapore
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.